We detected PCA3, PVT1, and GAS5 lincRNAs as differentially expressed genes in the patient cancer samples compared with adjacent non-tumor tissues; these lincRNAs have been recently shown to be associated with prostate cancer (Bawa et al., 2015; Shih et al., 2015). This evidence concerns the gene PCA3 and prostate carcinoma.